Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

Net product sales of CAPLYTA were $680.5 million for the full year 2024. This represents an increase of 47% compared to 2023.

There's a window of time in our lives we've all passed through yet still know so little about: early gestation. Researchers ...

Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to ...

University of California, Los Angeles researchers have discovered that chronic stress flips brain activity between two ...

A federal commission to examine U.S. chronic disease could undercut real treatment for kids with depression, ADHD and other ...

Mental health encompasses an individual's psychological and emotional well-being. Maintaining good mental health is crucial ...

From medical myths to media bias, misinformation is everywhere. Strengthen your ability to think critically and make informed ...

For some patients born with a certain skull abnormality, unexpectedly early cognitive decline and symptoms of depression and anxiety may be corrected with a brain surgery, report University of ...

Art Therapy, Mental Health, Efficacy, Developed Countries, Narrative Review, Non-Verbal Therapy, Accessibility, Mental Health ...